Cogent Biosciences (COGT) Net Cash Flow (2017 - 2021)
Historic Net Cash Flow for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $16.8 million.
- Cogent Biosciences' Net Cash Flow fell 8510.6% to $16.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$22.4 million, marking a year-over-year decrease of 11139.98%. This contributed to the annual value of $44.9 million for FY2024, which is 15111.48% up from last year.
- Per Cogent Biosciences' latest filing, its Net Cash Flow stood at $16.8 million for Q4 2021, which was down 8510.6% from -$15.2 million recorded in Q3 2021.
- Cogent Biosciences' 5-year Net Cash Flow high stood at $112.8 million for Q4 2020, and its period low was -$15.2 million during Q3 2021.
- In the last 5 years, Cogent Biosciences' Net Cash Flow had a median value of -$2.5 million in 2017 and averaged $8.5 million.
- Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 49701.67% in 2019, then skyrocketed by 143329.39% in 2020.
- Cogent Biosciences' Net Cash Flow (Quarter) stood at -$2.4 million in 2017, then surged by 371.28% to $6.4 million in 2018, then crashed by 232.67% to -$8.5 million in 2019, then surged by 1433.29% to $112.8 million in 2020, then crashed by 85.11% to $16.8 million in 2021.
- Its Net Cash Flow stands at $16.8 million for Q4 2021, versus -$15.2 million for Q3 2021 and -$12.5 million for Q2 2021.